LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of November 13, 2026, LIVN trades at $91.25 with a market cap of $4.97B and a P/E ratio of 22.01. LIVN moved +1.08% today. Year to date, LIVN is +44.23%; over the trailing twelve months it is +65.21%. Its 52-week range spans $32.48 to $99.38. Analyst consensus is strong buy with an average price target of $104.00. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LIVN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $91.25 |
| Market Cap | $4.97B |
| P/E Ratio | 22.01 |
| EPS | $3.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.38 |
| 52-Week Low | $32.48 |
| Volume | 561.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.47B |
| Net Income | $188.55M |
| Gross Margin | 68.10% |
7 analysts cover LIVN: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $104.00.